These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 16365873)
1. Molecular basis of interaction between NG2 proteoglycan and galectin-3. Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873 [TBL] [Abstract][Full Text] [Related]
2. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Burg MA; Nishiyama A; Stallcup WB Exp Cell Res; 1997 Aug; 235(1):254-64. PubMed ID: 9281375 [TBL] [Abstract][Full Text] [Related]
3. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. Burg MA; Grako KA; Stallcup WB J Cell Physiol; 1998 Nov; 177(2):299-312. PubMed ID: 9766527 [TBL] [Abstract][Full Text] [Related]
4. The expression of NG2 proteoglycan in the human intervertebral disc. Akeda K; An HS; Pichika R; Patel K; Muehleman C; Nakagawa K; Uchida A; Masuda K Spine (Phila Pa 1976); 2007 Feb; 32(3):306-14. PubMed ID: 17268261 [TBL] [Abstract][Full Text] [Related]
5. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Fukushi J; Makagiansar IT; Stallcup WB Mol Biol Cell; 2004 Aug; 15(8):3580-90. PubMed ID: 15181153 [TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer. Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858 [TBL] [Abstract][Full Text] [Related]
7. Interaction between DMBT1 and galectin 3 is modulated by the structure of the oligosaccharides carried by DMBT1. Rossez Y; Coddeville B; Elass E; Quinchon JF; Vidal O; Corfield AP; Gosset P; Lacroix JM; Michalski JC; Robbe-Masselot C Biochimie; 2011 Mar; 93(3):593-603. PubMed ID: 21167898 [TBL] [Abstract][Full Text] [Related]
8. NG2 expression regulates vascular morphology and function in human brain tumours. Brekke C; Lundervold A; Enger PØ; Brekken C; Stålsett E; Pedersen TB; Haraldseth O; Krüger PG; Bjerkvig R; Chekenya M Neuroimage; 2006 Feb; 29(3):965-76. PubMed ID: 16253523 [TBL] [Abstract][Full Text] [Related]
10. Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. Vladimirova V; Waha A; Lückerath K; Pesheva P; Probstmeier R J Neurosci Res; 2008 Aug; 86(11):2450-61. PubMed ID: 18438928 [TBL] [Abstract][Full Text] [Related]
11. NG2 proteoglycan-binding peptides target tumor neovasculature. Burg MA; Pasqualini R; Arap W; Ruoslahti E; Stallcup WB Cancer Res; 1999 Jun; 59(12):2869-74. PubMed ID: 10383148 [TBL] [Abstract][Full Text] [Related]
12. Biological applications of a chimeric probe for the assessment of galectin-3 ligands. de Melo FH; Butera D; Medeiros RS; Andrade LN; Nonogaki S; Soares FA; Alvarez RA; Moura da Silva AM; Chammas R J Histochem Cytochem; 2007 Oct; 55(10):1015-26. PubMed ID: 17565118 [TBL] [Abstract][Full Text] [Related]
13. Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma. Suzuki O; Nozawa Y; Abe M Oncol Rep; 2005 Jan; 13(1):109-14. PubMed ID: 15583810 [TBL] [Abstract][Full Text] [Related]
14. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Ozerdem U; Grako KA; Dahlin-Huppe K; Monosov E; Stallcup WB Dev Dyn; 2001 Oct; 222(2):218-27. PubMed ID: 11668599 [TBL] [Abstract][Full Text] [Related]
15. The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells. Levine JM; Nishiyama A Perspect Dev Neurobiol; 1996; 3(4):245-59. PubMed ID: 9117258 [TBL] [Abstract][Full Text] [Related]
16. Multifaceted role of galectin-3 on human glioblastoma cell motility. Debray C; Vereecken P; Belot N; Teillard P; Brion JP; Pandolfo M; Pochet R Biochem Biophys Res Commun; 2004 Dec; 325(4):1393-8. PubMed ID: 15555581 [TBL] [Abstract][Full Text] [Related]
17. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Zou J; Glinsky VV; Landon LA; Matthews L; Deutscher SL Carcinogenesis; 2005 Feb; 26(2):309-18. PubMed ID: 15528216 [TBL] [Abstract][Full Text] [Related]
18. Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration. Makagiansar IT; Williams S; Mustelin T; Stallcup WB J Cell Biol; 2007 Jul; 178(1):155-65. PubMed ID: 17591920 [TBL] [Abstract][Full Text] [Related]
19. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3. Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296 [TBL] [Abstract][Full Text] [Related]
20. Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule-specific phenotype. Murfee WL; Skalak TC; Peirce SM Microcirculation; 2005 Mar; 12(2):151-60. PubMed ID: 15824037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]